Screen-detected cognitive impairment, psychological distress, and quality of life in cancer patients undergoing chemotherapy in Yemen
Al-Hassan Alkhafaji, Haidara Alkhafaji, Mohammed Alabsi, Mohammed Alarasi, Sayida Al-Jamei · 2026
Read Screen-detected cognitive impairment, psychological distress, and quality of life in cancer patients undergoing chemotherapy in Yemen by Al-Hassan Alkhafaji, Haidara Alkhafaji, Mohammed Alabsi, Mohammed Alarasi, Sayida Al-Jamei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13397810.txt.
Description
Al-Hassan Alkhafaji and colleagues screened cancer patients receiving chemotherapy in Yemen for thinking problems, distress, and quality of life. Their 2026 study took place at the National Oncology Center in Sana'a during June and July 2025, where cancer care data and resources are scarce. Chemotherapy can affect memory, mood, and daily function, yet little was known about how often these effects appear in Yemeni patients.
Among 167 adults, most with advanced cancer, only 6 percent showed normal cognition on screening, while 94 percent screened positive for impairment, mainly in language and visual-spatial skills. About one in five showed borderline or abnormal anxiety or depression, and quality-of-life scores ran below average. Older age, male sex, and smoking tracked with lower cognition, while more education tracked with higher scores. The paper calls for routine screening and support in Yemeni oncology care.
Catalog record
| CREATOR | Al-Hassan Alkhafaji, Haidara Alkhafaji, Mohammed Alabsi, Mohammed Alarasi, Sayida Al-Jamei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |